1.Anderson DJ, Kaye KS, Classen D, et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29(suppl 1):S51–S61.
2.Yokoe DS, Anderson DJ, Berenholtz SM, et al. Introduction to “A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates.” Infect Control Hosp Epidemiol 2014;35(5):455–459.
3.Cruse P.Wound infection surveillance. Rev Infect Dis 1981;3(4):734–737.
4.Graves EJ. National Hospital Discharge Survey: Annual Summary, 1987. Series 13, no. 99. Hyattsville, MD: National Center for Health Statistics, 1989.
5.Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project—statistics on hospital stays. 2013. http://hcupnet.ahrq.gov/. Accessed February 15, 2013. 6.Scott RD. The Direct Medical Costs of Healthcare-Associated Infections in U.S. Hospitals and the Benefits of Prevention. Atlanta: Centers for Disease Control and Prevention, 2009. http://www.cdc.gov/hai/pdfs/hai/scott_costpaper.pdf. Accessed December 14, 2013.
7.Anderson DJ, Pyatt DG, Weber DJ, Rutala WA. Statewide costs of health care-associated infections: estimates for acute care hospitals in North Carolina. Am J Infect Control 2013;41(9): 764–768.
8.Lewis SS, Moehring RW, Chen LF, Sexton DJ, Anderson DJ. Assessing the relative burden of hospital-acquired infections in a network of community hospitals. Infect Control Hosp Epidemiol 2013;34(11):1229–1230.
9.Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the us health care system. JAMA Intern Med 2013; 173(22):2039–2046.
10.Meeks DW, Lally KP, Carrick MM, et al. Compliance with guidelines to prevent surgical site infections: as simple as 1-2-3? Am J Surg 2011;201(1):76–83.
11.Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol 2011;32(2): 101–114.
12.Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007;122(2):160–166.
13.Cruse PJ, Foord R.The epidemiology of wound infection: a 10-year prospective study of 62,939 wounds. Surg Clin North Am 1980;60(1):27–40.
14.Anderson DJ, Kaye KS, Chen LF, et al. Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study. PloS ONE 2009;4(12):e8305.
15.Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003;36(5):592–598.
16.Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999;20(11):725–730.
17.Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR; Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 1999;20(4):250–278.
18.Apisarnthanarak A, Jones M, Waterman BM, Carroll CM, Bernardi R, Fraser VJ. Risk factors for spinal surgical-site infections in a community hospital: a case-control study. Infect Control Hosp Epidemiol 2003;24(1):31–36.
19.Boyce JM, Potter-Bynoe G, Dziobek L.Hospital reimbursement patterns among patients with surgical wound infections following open heart surgery. Infect Control Hosp Epidemiol 1990; 11(2):89–93.
20.Coello R, Glenister H, Fereres J, et al. The cost of infection in surgical patients: a case-control study. J Hosp Infect 1993;25(4): 239–250.
21.Hollenbeak CS, Murphy DM, Koenig S, Woodward RS, Dunagan WC, Fraser VJ. The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest 2000;118(2):397–402.
22.VandeBergh MF, Kluytmans JA, van Hout BA, et al. Cost-effectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery. Infect Control Hosp Epidemiol 1996;17(12): 786–792.
23.Vegas AA, Jodra VM, Garcia ML. Nosocomial infection in surgery wards: a controlled study of increased duration of hospital stays and direct cost of hospitalization. Eur J Epidemiol 1993; 9(5):504–510.
24.Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002;23(4):183–189.
25.Bozic KJ, Katz P, Cisternas M, Ono L, Ries MD, Showstack J.Hospital resource utilization for primary and revision total hip arthroplasty. J Bone Joint Surg Am 2005;87(3):570–576.
27.Condon RE, Schulte WJ, Malangoni MA, Anderson-Teschendorf MJ. Effectiveness of a surgical wound surveillance program. Arch Surg 1983;118(3):303–307.
28.Kerstein M, Flower M, Harkavy LM, Gross PA. Surveillance for postoperative wound infections: practical aspects. Am Surg 1978;44(4):210–214.
29.Mead PB, Pories SE, Hall P, Vacek PM, Davis JH Jr, Gamelli RL. Decreasing the incidence of surgical wound infections: validation of a surveillance-notification program. Arch Surg 1986; 121(4):458–461.
30.Baker C, Luce J, Chenoweth C, Friedman C.Comparison of case-finding methodologies for endometritis after cesarean section. Am J Infect Control 1995;23(1):27–33.
31.Cardo DM, Falk PS, Mayhall CG. Validation of surgical wound surveillance. Infect Control Hosp Epidemiol 1993;14(4):211–215.
32.Ming DY, Chen LF, Miller BA, Anderson DJ. The impact of depth of infection and postdischarge surveillance on rate of surgical-site infections in a network of community hospitals. Infect Control Hosp Epidemiol 2012;33(3):276–282.
33.Chalfine A, Cauet D, Lin WC, et al. Highly sensitive and efficient computer-assisted system for routine surveillance for surgical site infection. Infect Control Hosp Epidemiol 2006;27(8): 794–801.
34.Miner AL, Sands KE, Yokoe DS, et al. Enhanced identification of postoperative infections among outpatients. Emerg Infect Dis 2004;10(11):1931–1937.
35.Yokoe DS, Noskin GA, Cunnigham SM, et al. Enhanced identification of postoperative infections among inpatients. Emerg Infect Dis 2004;10(11):1924–1930.
36.Calderwood MS, Kleinman K, Bratzier DW, et al. Use of Medicare claims to identify US hospitals with a high rate of surgical site infection after hip arthroplasty. Infect Control Hosp Epidemiol 2013;34(1):31–39.
37.Huang SS, Placzek H, Livingston J, et al. Use of Medicare claims to rank hospitals by surgical site infection risk following coronary artery bypass graft surgery. Infect Control Hosp Epidemiol 2011;32(8):775–783.
38.Haley VB, Van Antwerpen C, Tserenpuntsag B, et al. Use of administrative data in efficient auditing of hospital-acquired surgical site infections, New York State 2009-2010. Infect Control Hosp Epidemiol 2012;33(6):565–571.
39.Burke JP. Infection control—a problem for patient safety. N Engl J Med 2003;348(7):651–656.
40.Cullen KA, Hall MJ, Golosinkiy A.Ambulatory surgery in the United States, 2006. Nati Health Stat Report 2009;(11):1–25.
42.Consensus paper on the surveillance of surgical wound infections. The Society for Hospital Epidemiology of America; the Association for Practitioners in Infection Control; the Centers for Disease Control; the Surgical Infection Society. Infect Control Hosp Epidemiol 1992;13(10):599–605.
43.Mannien J, Wille JC, Snoeren RL, van den Hof S.Impact of postdischarge surveillance on surgical site infection rates for several surgical procedures: results from the nosocomial surveillance network in the Netherlands. Infect Control Hosp Epidemiol 2006;27(8):809–816.
44.Kent P, McDonald M, Harris O, Mason T, Spelman D.Post-discharge surgical wound infection surveillance in a provincial hospital: follow-up rates, validity of data and review of the literature. ANZJ Surg 2001;71(10):583–589.
45.Manian FA. Surveillance of surgical site infections in alternative settings: exploring the current options. Am J Infect Control 1997;25(2):102–105.
46.Michelson J.Improved detection of orthopaedic surgical site infections occurring in outpatients. Clin Orthop Relat Res 2005(433):218–224.
47.Nafziger DA, Lundstrom T, Chandra S, Massanari RM. Infection control in ambulatory care. Infect Dis Clin North Am 1997; 11(2):279–296.
48.Petherick ES, Dalton JE, Moore PJ, Cullum N.Methods for identifying surgical wound infection after discharge from hospital: a systematic review. BMC Infect Dis 2006;6:170.
49.Mlangeni D, Babikir R, Dettenkofer M, Daschner F, Gastmeier P, Ruden H.AMBU-KISS: quality control in ambulatory surgery. Am J Infect Control 2005;33(1):11–14.
50.Whitby M, McLaws ML, Collopy B, et al. Post-discharge surveillance: can patients reliably diagnose surgical wound infections? J Hosp Infect 2002;52(3):155–160.
51.Manian FA, Meyer L.Comparison of patient telephone survey with traditional surveillance and monthly physician questionnaires in monitoring surgical wound infections. Infect Control Hosp Epidemiol 1993;14(4):216–218.
52.Prospero E, Cavicchi A, Bacelli S, Barbadoro P, Tantucci L, D’Errico MM. Surveillance for surgical site infection after hospital discharge: a surgical procedure-specific perspective. Infect Control Hosp Epidemiol 2006;27(12):1313–1317.
53.Sands K, Vineyard G, Platt R.Surgical site infections occurring after hospital discharge. J Infect Dis 1996;173(4):963–970.
57.Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004;38(12):1706–1715.
58.Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 2006;43(3):322–330.
59.Dellinger EP, Hausmann SM, Bratzler DW, et al. Hospitals collaborate to decrease surgical site infections. Am J Surg 2005; 190(1):9–15.
60.National Quality Forum (NQF). Cardiac Surgery Patients with Controlled Postoperative Blood Glucose. Washington, DC: NQF, 2013. http://www.qualityforum.org/. Accessed January 6, 2013.
61.Lazar HL, McDonnell M, Chipkin SR, et al. The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann Thorac Surg 2009;87(2):663–669.
62.A resource from the Institute of Healthcare Improvement. Institute for Healthcare Improvement (IHI) website, http://www.ihi.org. Accessed January 31, 2007.
63.Griffin FA. Reducing surgical complications. Jt Comm J Qual Patient Saf 2007;33(11):660–665.
65.Centers for Medicare & Medicaid Services. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and fiscal year 2013 rates; hospitals’ resident caps for graduate medical education payment purposes; quality reporting requirements for specific providers and for ambulatory surgical centers. Final rule. Fed Regist 2012;77(170):53257–53750.
66.Centers for Medicare & Medicaid Services. Medicare program; hospital inpatient value-based purchasing program. Final rule. Fed Regist 2011;76(88):26490–26547.
67.van Kasteren ME, Mannien J, Kullberg BJ, et al. Quality improvement of surgical prophylaxis in Dutch hospitals: evaluation of a multi-site intervention by time series analysis. J Antimicrob Chemother 2005;56(6):1094–1102.
68.Schweon S.Stamping out surgical site infections. RN 2006; 69(8):36–40.
69.Torpy JM, Burke A, Glass RM. JAMA patient page: wound infections. JAMA 2005;294(16):2122.
70.Kanter G, Connelly NR, Fitzgerald J.A system and process redesign to improve perioperative antibiotic administration. Anesth Analg 2006;103(6):1517–1521.
71.Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 1996;124(10):884–890.
72.Webb AL, Flagg RL, Fink AS. Reducing surgical site infections through a multidisciplinary computerized process for preoperative prophylactic antibiotic administration. Am J Surg 2006; 192(5):663–668.
73.Nair BG, Newman SF, Peterson GN, Wu WY, Schwid HA. Feedback mechanisms including real-time electronic alerts to achieve near 100% timely prophylactic antibiotic administration in surgical cases. Anesth Analg 2010;111(5):1293–1300.
74.Berger RG, Kichak JP. Computerized physician order entry: helpful or harmful? J Am Med Inform Assoc 2004;11(2):100–103.
75.Antimicrobial prophylaxis for surgery. Treat Guidel Med Lett 2009;7(82):47–52.
76.Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013;70(3): 195–283.
77.Steinberg JP, Braun BI, Hellinger WC, et al. Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors. Ann Surg 2009;250(1):10–16.
78.van Kasteren ME, Mannien J, Ott A, Kullberg BJ, de Boer AS, Gyssens IC. Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor. Clin Infect Dis 2007;44(7): 921–927.
79.Soriano A, Bori G, Garcia-Ramiro S, et al. Timing of antibiotic prophylaxis for primary total knee arthroplasty performed during ischemia. Clin Infect Dis 2008;46(7):1009–1014.
80.Akinyoola AL, Adegbehingbe OO, Odunsi A.Timing of antibiotic prophylaxis in tourniquet surgery. J Foot Ankle Surg 2011;50(4):374–376.
81.Harbarth S, Samore MH, Lichtenberg D, Carmeli Y.Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 2000;101(25):2916–2921.
82.McDonald M, Grabsch E, Marshall C, Forbes A.Single-versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust N ZJ Surg 1998;68(6):388–396.
83.Coakley BA, Sussman ES, Wolfson TS, et al. Postoperative antibiotics correlate with worse outcomes after appendectomy for nonperforated appendicitis. J Am Coll Surg 2011;213(6):778–783.
84.Cannon JA, Altom LK, Deierhoi RJ, et al. Preoperative oral antibiotics reduce surgical site infection following elective co-lorectal resections. Dis Colon Rectum 2012;55(11):1160–1166.
85.Englesbe MJ, Brooks L, Kubus J, et al. A statewide assessment of surgical site infection following colectomy: the role of oral antibiotics. Ann Surg 2010;252(3):514–519.
86.Fry DE. Colon preparation and surgical site infection. Am J Surg 2011;202(2):225–232.
87.Hendren S, Fritze D, Banerjee M, et al. Antibiotic choice is independently associated with risk of surgical site infection after colectomy: a population-based cohort study. Ann Surg 2013;257(3):469–475.
88.Lewis RT. Oral versus systemic antibiotic prophylaxis in elective colon surgery: a randomized study and meta-analysis send a message from the 1990s. Can J Surg 2002;45(3):173–180.
89.Nelson RL, Glenny AM, Song F.Antimicrobial prophylaxis for colorectal surgery. Cochrane Database Syst Rev 2009;(1):CD001181.
90.Deierhoi RJ, Dawes LG, Vick C, Itani KM, Hawn MT. Choice of intravenous antibiotic prophylaxis for colorectal surgery does matter. J Am Coll Surg 2013;217(5):763–769.
91.Toneva GD, Deierhoi RJ, Morris M, et al. Oral antibiotic bowel preparation reduces length of stay and readmissions after colorectal surgery. J Am Coll Surg 2013;216(4):756–762.
92.Guenaga KF, Matos D, Wille-Jorgensen RMechanical bowel preparation for elective colorectal surgery. Cochrane Database Syst Rev 2011;(9):CD001544.
93.Tanner J, Woodings D, Moncaster K.Preoperative hair removal to reduce surgical site infection. Cochrane Database Syst Rev 2006;(3):CD004122.
94.Dronge AS, Perkal MF, Kancir S, Concato J, Asian M, Rosenthal RA. Long-term glycémie control and postoperative infectious complications. Arch Surg 2006;141(4):375–380.
95.Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 1999; 22(9):1408–1414.
96.Olsen MA, Nepple JJ, Riew KD, et al. Risk factors for surgical site infection following orthopaedic spinal operations. J Bone Joint Surg Am 2008;90(1):62–69.
97.Kwon S, Thompson R, Dellinger P, Yanez D, Farrohki E, Flum D.Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program. Ann Surg 2013;257(1):8–14.
98.Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care 2011;34(2):256–261.
99.Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med 2012;40(12):3251–3276.
100.Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrino J Metab 2012;97(1):16–38.
101.Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 2007;146(4):233–243.
102.Sessler DI. Complications and treatment of mild hypothermia. Anesthessiology 2001;95(2):531–543.
103.Kurz A, Sessler DI, Lenhardt R; Study of Wound Infection and Temperature Group. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitali-zation. N Engl J Med 1996;334(19):1209–1215.
104.Melling AC, Ali B, Scott EM, Leaper DJ. Effects of preoperative warming on the incidence of wound infection after clean surgery: a randomised controlled trial. Lancet 2001;358(9285): 876–880.
105.Wong PF, Kumar S, Bohra A, Whetter D, Leaper DJ. Randomized clinical trial of perioperative systemic warming in major elective abdominal surgery. Br J Surg 2007;94(4):421–426.
106.Belda FJ, Aguilera L, Garcia de la Asuncion J, et al. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA 2005;294(16): 2035–2042.
107.Greif R, Akca O, Horn EP, Kurz A, Sessler DI; Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. N Engl J Med 2000; 342(3):161–167.
108.Bickel A, Gurevits M, Vamos R, Ivry S, Eitan A.Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis: a randomized, prospective, controlled trial. Arch Surg 2011;146(4):464–470.
109.Meyhoff CS, Wetterslev J, Jorgensen LN, et al. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA 2009;302(14):1543–1550.
110.Pryor KO, Fahey TJ 3rd, Lien CA, Goldstein PA. Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA 2004;291(1):79–87.
111.Schietroma M, Carlei F, Cecilia EM, Piccione F, Bianchi Z, Amicucci G.Colorectal infraperitoneal anastomosis: the effects of perioperative supplemental oxygen administration on the anastomotic dehiscence. J Gastrointest Surg 2012;16(2):427–434.
112.Schietroma M, Cecilia EM, Carlei F, et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double-blind, controlled, single-center trial. Ann Surg Oncol 2013;20(5):1584–1590.
113.Meyhoff CS, Jorgensen LN, Wetterslev J, Christensen KB, Rasmussen LS. Increased long-term mortality after a high perioperative inspiratory oxygen fraction during abdominal surgery: follow-up of a randomized clinical trial. Anesth Analg 2012; 115(4):849–854.
114.Qadan M, Akca O, Mahid SS, Hornung CA, Polk HCJr. Perioperative supplemental oxygen therapy and surgical site infection: a meta-analysis of randomized controlled trials. Arch Surg 2009;144(4):359–366.
115.Maiwald M, Chan ES. The forgotten role of alcohol: a systematic review and meta-analysis of the clinical efficacy and perceived role of chlorhexidine in skin antisepsis. PloS ONE 2012;7(9):e44277.
116.Darouiche RO, Wall MJ Jr, Itani KM, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 2010;362(1):18–26.
117.Swenson BR, Hedrick TL, Metzger R, Bonatti H, Pruett TL, Sawyer RG. Effects of preoperative skin preparation on postoperative wound infection rates: a prospective study of 3 skin preparation protocols. Infect Control Hosp Epidemiol 2009; 30(10):964–971.
118.Aly R, Maibach HI. Comparative antibacterial efficacy of a 2-minute surgical scrub with chlorhexidine gluconate, povidone-iodine, and chloroxylenol sponge-brushes. Am J Infect Control 1988;16(4):173–177.
119.Larson E.Guideline for use of topical antimicrobial agents. Am J Infect Control 1988;16(6):253–266.
120.Edwards JP, Ho AL, Tee MC, Dixon E, Ball CG. Wound protectors reduce surgical site infection: a meta-analysis of randomized controlled trials. Ann Surg 2012;256(1):53–59.
121.Haynes AB, Weiser TG, Berry WR, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med 2009;360(5):491–499.
122.Weiser TG, Haynes AB, Dziekan G, Berry WR, Lipsitz SR, Gawande AA. Effect of a 19-item surgical safety checklist during urgent operations in a global patient population. Ann Surg 2010;251(5):976–980.
123.van Klei WA, Hoff RG, van Aarnhem EE, et al. Effects of the introduction of the WHO “Surgical Safety Checklist” on in hospital mortality: a cohort study. Ann Surg 2012;255(1):44–49.
124.Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121(2):182–205.
125.Lee JT. Wound infection surveillance. Infect Dis Clin North Am 1992;6(3):643–656.
126.Calderwood MS, Ma A, Khan YM, et al. Use of Medicare diagnosis and procedure codes to improve detection of surgical site infections following hip arthroplasty, knee arthroplasty, and vascular surgery. Infect Control Hosp Epidemiol 2012;33(1):40–49.
127.Bolon MK, Hooper D, Stevenson KB, et al. Improved surveillance for surgical site infections after orthopedic implantation procedures: extending applications for automated data. Clin Infect Dis 2009;48(9):1223–1229.
128.Gerbier-Colomban S, Bourjault M, Cetre JC, Baulieux J, Metzger MH. Evaluation study of different strategies for detecting surgical site infections using the hospital information system at Lyon University Hospital, France. Ann Surg 2012;255(5): 896–900.
129.Yokoe DS, Khan Y, Olsen MA, et al. Enhanced surgical site infection surveillance following hysterectomy, vascular, and colorectal surgery. Infect Control Hosp Epidemiol 2012;33(8):768–773.
130.Jamtvedt G, Young JM, Kristoffersen DT, O’Brien MA, Oxman AD. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2006;(2): CD000259.
131.Skoufalos A, Clarke JL, Napp M, et al. Improving awareness of best practices to reduce surgical site infection: a multistake-holder approach. Am J Med Qual 2012;27(4):297–304.
132.Association of periOperative Registered Nurses. 2013. http://www.aorn.org/. Accessed March 23, 2013.
133.Culver DH, Horan TC, Gaynes RP, et al; National Nosocomial Infections Surveillance System. Surgical wound infection rates by wound class, operative procedure, and patient risk index. Am J Med 1991;91(3 B):152S–157S.
134.Loftus RW, Brown JR, Koff MD, et al. Multiple reservoirs contribute to intraoperative bacterial transmission. Anesth Analg 2012;114(6):1236–1248.
135.Andersson AE, Bergh I, Karlsson J, Eriksson BI, Nilsson K.Traffic flow in the operating room: an explorative and descriptive study on air quality during orthopedic trauma implant surgery. Am J Infect Control 2012;40(8):750–755.
136.Crolla RM, van der Laan L, Veen EJ, Hendriks Y, van Schendel C, Kluytmans J.Reduction of surgical site infections after implementation of a bundle of care. PloS ONE 2012;7(9):e44599.
137.van Rijen M, Bonten M, Wenzel R, Kluytmans J.Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev 2008;(4):CD006216.
138.Wilcox MH, Hall J, Pike H, et al. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect 2003; 54(31):196–201.
139.Nicholson MR, Huesman LA. Controlling the usage of intra-nasal mupirocin does impact the rate of Staphylococcus aureus deep sternal wound infections in cardiac surgery patients. Am J Infect Control 2006;34(1):44–48.
140.Walsh EE, Greene L, Kirshner R.Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery. Arch Intern Med 2011; 171(1):68–73.
141.Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010;362(1):9–17.
142.Harbarth S, Fankhauser C, Schrenzel J, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008;299(10):1149–1157.
143.Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002;346(24):1871–1877.
144.Schweizer M, Perencevich E, McDanel J, et al. Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and meta-analysis. BMJ 2013;346:f2743.
145.Miller MA, Dascal A, Portnoy J, Mendelson J.Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996;17(12):811–813.
146.Whiteside OJ, Tytherleigh MG, Thrush S, Farouk R, Galland RB. Intra-operative peritoneal lavage—who does it and why? Ann R Coll Surg Engl 2005;87(4):255–258.
147.Fournel I, Tiv M, Soulias M, Hua C, Astruc K, Aho Glele LS. Meta-analysis of intraoperative povidone-iodine application to prevent surgical-site infection. Br J Surg 2010;97(11):1603–1613.
148.Thompson KM, Oldenburg WA, Deschamps C, Rupp WC, Smith CD. Chasing zero: the drive to eliminate surgical site infections. Ann Surg 2011;254(3):430–436.
149.Haessler S, Connelly NR, Kanter G, et al. A surgical site infection cluster: the process and outcome of an investigation—the impact of an alcohol-based surgical antisepsis product and human behavior. Anesth Analg 2010;110(4):1044–1048.
150.Panahi P, Stroh M, Casper DS, Parvizi J, Austin MS. Operating room traffic is a major concern during total joint arthroplasty. Clin Orthop Relat Res 2012;470(10):2690–2694.
151.Tadros MA, Williams VR, Plourde S, Callery S, Simor AE, Vearncombe M.Risk factors for Staphylococcus aureus surgical site infection during an outbreak in patients undergoing cardiovascular surgery. Am J Infect Control 2013;41(6):509–512.
152.Wiener-Well Y, Galuty M, Rudensky B, Schlesinger Y, Attias D, Yinnon AM. Nursing and physician attire as possible source of nosocomial infections. Am J Infect Control 2011;39(7):555–559.
153.Wright SN, Gerry JS, Busowski MT, et al. Gordonia bronchialis sternal wound infection in 3 patients following open heart surgery: intraoperative transmission from a healthcare worker. Infect Control Hosp Epidemiol 2012;33(12):1238–1241.
154.Kohlenberg A, Weitzel-Kage D, van der Linden P, et al. Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit. J Hosp Infect 2010;74(4): 350–357.
155.Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee (HICPAC). Management of Multidrug-Resistant Organisms in Healthcare Settings, 2006. Atlanta: Centers for Disease Control and Prevention, 2006. http://www.cdc.gov/hicpac/pdf/MDRO/MDROGuideline2006.pdf. Accessed January 3, 2014.
156.Dodds Ashley ES, Carroll DN, Engemann JJ, et al. Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2004;38(11):1555–1560.
157.Chambers D, Worthy G, Myers L, et al. Glycopeptide vs. non-glycopeptide antibiotics for prophylaxis of surgical site infections: a systematic review. Surg Infect (Larchmt) 2010;11(5): 455–462.
158.Bolon MK, Morlote M, Weber SG, Koplan B, Carmeli Y, Wright SB. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin Infect Dis 2004;38(10):1357–1363.
159.Bull AL, Worth LJ, Richards MJ. Impact of vancomycin surgical antibiotic prophylaxis on the development of methicillin-sensitive Staphylococcus aureus surgical site infections: report from Australian Surveillance Data (VICNISS). Ann Surg 2012; 256(6):1089–1092.
160.Brennan MF, Pisters PW, Posner M, Quesada O, Shike M.A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann Surg 1994; 220(4):436–441.
161.Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative total parenteral nutrition in surgical patients. N Engl J Med 1991;325(8):525–532.
162.Marimuthu K, Varadhan KK, Ljungqvist O, Lobo DN. A meta-analysis of the effect of combinations of immune modulating nutrients on outcome in patients undergoing major open gastrointestinal surgery. Ann Surg 2012;255(6):1060–1068.
163.Zhang Y, Gu Y, Guo T, Li Y, Cai H.Perioperative immuno-nutrition for gastrointestinal cancer: a systematic review of randomized controlled trials. Surg Oncol 2012;21(2):e87–e95.
164.Elek SD, Conen PE. The virulence of Staphylococcus pyogenes for man: a study of the problems of wound infection. Br J Exp Pathol 1957;38(6):573–586.
165.Nakamura T, Kashimura N, Noji T, et al. Triclosan-coated sutures reduce the incidence of wound infections and the costs after colorectal surgery: a randomized controlled trial. Surgery 2013;153(4):576–583.
166.Chang WK, Srinivasa S, Morton R, Hill AG. Triclosan-impregnated sutures to decrease surgical site infections: systematic review and meta-analysis of randomized trials. Ann Surg 2012;255(5):854–859.
167.Deliaert AE, Van den Kerckhove E, Tuinder S, et al. The effect of triclosan-coated sutures in wound healing: a double blind randomised prospective pilot study. J Plast Reconstr Aesthet Surg 2009;62(6):771–773.
168.Webster J, Alghamdi AA. Use of plastic adhesive drapes during surgery for preventing surgical site infection. Cochrane Database Syst Rev 2007;(4):CD006353.
169.Cordtz T, Schouenborg L, Laursen K, et al. The effect of incisional plastic drapes and redisinfection of operation site on wound infection following caesarean section. J Hosp Infect 1989;13(3):267–272.
170.Dewan PA, Van Rij AM, Robinson RG, Skeggs GB, Fergus M.The use of an iodophor-impregnated plastic incise drape in abdominal surgery—a controlled clinical trial. Aust N Z J Surg 1987;57(11):859–863.
171.Segal CG, Anderson JJ. Preoperative skin preparation of cardiac patients. AORN J 2002;76(5):821–828.
172.Swenson BR, Camp TR, Mulloy DP, Sawyer RG. Antimicrobial-impregnated surgical incise drapes in the prevention of mesh infection after ventral hernia repair. Surg Infect (Larchmt) 2008; 9(1):23–32.
173.Kaul AF, Jewett JF. Agents and techniques for disinfection of the skin. Surg Gynecol Obstet 1981;152(5):677–685.
174.Webster J, Osborne S.Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev 2007;(2):CD004985.
175.Edmiston CE Jr, Krepel CJ, Seabrook GR, Lewis BD, Brown KR, Towne JB. Preoperative shower revisited: can high topical antiseptic levels be achieved on the skin surface before surgical admission? J Am Coll Surg 2008;207(2):233–239.
176.Eiselt D.Presurgical skin preparation with a novel 2% chlorhexidine gluconate cloth reduces rates of surgical site infection in orthopaedic surgical patients. Orthop Nurs 2009;28(3):141–145.
177.Segers P, Speekenbrink RG, Ubbink DT, van Ogtrop ML, de Mol BA. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. JAMA 2006;296(20):2460–2466.
178.de Bruin AF, Gosselink MP, van der Harst E, Rutten HJ. Local application of gentamicin collagen implants in the prophylaxis of surgical site infections following gastrointestinal surgery: a review of clinical experience. Tech Coropractol 2010;14(4):301–310.
179.Guzmán Valdivia Gomez G, Guerrero TS, Lluck MC, Delgado FJ. Effectiveness of collagen-gentamicin implant for treatment of “dirty” abdominal wounds. World J Surg 1999;23(2):123–126.
180.Rutten HJ, Nijhuis PH. Prevention of wound infection in elective colorectal surgery by local application of a gentamicin-containing collagen sponge. Eur J Surg Suppl 1997;(578):31–35.
181.Bennett-Guerrero E, Pappas TN, Koltun WA, et al. Gentamicin-collagen sponge for infection prophylaxis in colorectal surgery. N Engl J Med 2010;363(11):1038–1049.
182.Eklund AM, Valtonen M, Werkkala KA. Prophylaxis of sternal wound infections with gentamicin-collagen implant: randomized controlled study in cardiac surgery, J Hosp Infect 2005; 59(2):108–112.
183.Friberg O, Svedjeholm R, Soderquist B, Granfeldt H, Vikerfors T, Kallman J.Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial. Ann Thome Surg 2005;79(1):153–161.
184.Schimmer C, Ozkur M, Sinha B, et al. Gentamicin-collagen sponge reduces sternal wound complications after heart surgery: a controlled, prospectively randomized, double-blind study, J Thorac Cardiovasc Surg 2012;143(1):194–200.
185.Bennett-Guerrero E, Ferguson TB Jr, Lin M, et al. Effect of an implantable gentamicin-collagen sponge on sternal wound infections following cardiac surgery: a randomized trial. JAMA 2010;304(7):755–762.
186.Mavros MN, Mitsikostas PK, Alexiou VG, Peppas G, Falagas ME. Gentamicin collagen sponges for the prevention of sternal wound infection: a meta-analysis of randomized controlled trials. J Thorac Cardiovasc Surg 2012;144(5):1235–1240.
187.Anthony T, Murray BW, Sum-Ping JT, et al. Evaluating an evidence-based bundle for preventing surgical site infection: a randomized trial. Arch Surg 2011;146(3):263–269.
188.Young-Xu Y, Neily J, Mills PD, et al. Association between implementation of a medical team training program and surgical morbidity. Arch Surg 2011;146(12):1368–1373.
189.Malpiedi PJ, Peterson KD, Soe MM, et al. 2011 National and State Healthcare-Associated Infection Standardized Infection Ratio Report. Atlanta: National Center for Emerging and Zoonotic Infectious Diseases, 2013. http://www.cdc.gov/hai/pdfs/SIR/SIR-Report_02_07_2013.pdf. Accessed May 13, 2013.
190.Mu Y, Edwards JR, Horan TC, Berrios-Torres SI, Fridkin SK. Improving risk-adjusted measures of surgical site infection for the national healthcare safety network. Infect Control Hosp Epidemiol 2011;32(10):970–986.
191.Gaynes RP, Solomon S.Improving hospital-acquired infection rates: the CDC experience. Jt Comm J Qual Improv 1996;22(7): 457–467.
192.Moehring RW, Anderson DJ. “But my patients are different!”: risk adjustment in 2012 and beyond. Infect Control Hosp Epidemiol 2011;32(10):987–989.
193.Berrios-Torres SI, Mu Y, Edwards JR, Horan TC, Fridkin SK. Improved risk adjustment in public reporting: coronary artery bypass graft surgical site infections. Infect Control Hosp Epidemiol 2012;33(5):463–469.
194.Wong ES, Rupp ME, Mermel L, et al. Public disclosure of healthcare-associated infections: the role of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 2005;26(2):210–212.
195.McKibben L, Horan T, Tokars JI, et al. Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Am J Infect Control 2005;33(4):217–226.
196.Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and FY 2012 rates; hospitals’ FTE resident caps for graduate medical education payment. Final rules. Fed Regist 2011;76(160):51476–51846.
197.Medicare program; hospital outpatient prospective payment system and CY 2007 payment rates; CY 2007 update to the ambulatory surgical center covered procedures list; Medicare administrative contractors; and reporting hospital quality data for FY 2008 inpatient prospective payment system annual payment update program—HCAHPS survey, SCIP, and mortality. Final rule with comment period and final rule. Fed Regist 2006; 71(226):67959–68401.
198.National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). Operational Guidance for Reporting Surgical Site Infection (SSI) Data to CDC’s NHSNfor the Purpose of CMS’s Fulfilling Hospital Inpatient Quality Reporting (IQR) Program Requirements. Atlanta: NCEZID, 2012. http://www.cdc.gov/nhsn/PDFs/FINAL-ACH-SSI-Guidance.pdf. Accessed March 29, 2013.
199.Pronovost PJ, Berenholtz SM, Needham DM. Translating evidence into practice: a model for large scale knowledge translation. BMJ 2008;337:a1714.
200.Wick EC, Hobson DB, Bennett JL, et al. Implementation of a surgical comprehensive unit-based safety program to reduce surgical site infections. J Am Coll Surg 2012;215(2):193–200.
201.Ritter MA, French ML, Eitzen HE, Gioe TJ. The antimicrobial effectiveness of operative-site preparative agents: a microbiological and clinical study. J Bone Joint Surg Am 1980;62(5):826–828.
204.Ballard MR, Miller NH, Nyquist AC, Elise B, Baulesh DM, Erickson MA. A multidisciplinary approach improves infection rates in pediatric spine surgery. J Pediatr Orthop 2012;32(3): 266–270.
205.Cima R, Dankbar E, Lovely J, et al. Colorectal surgery surgical site infection reduction program: a national surgical quality improvement program-driven multidisciplinary single-institution experience. J Am Coll Surg 2013;216(1):23–33.
206.Hranjec T, Swenson BR, Sawyer RG. Surgical site infection prevention: how we do it. Surg Infect (Larchmt) 2010;11(3): 289–294.
207.Jain M, Miller L, Belt D, King D, Berwick DM. Decline in ICU adverse events, nosocomial infections and cost through a quality improvement initiative focusing on teamwork and culture change. Qual Saf Health Care 2006;15(4):235–239.
208.Alexander JW, Solomkin JS, Edwards MJ. Updated recommendations for control of surgical site infections. Ann Surg 2011;253(6):1082–1093.
209.Hendren S, Englesbe MJ, Brooks L, Kubus J, Yin H, Campbell DAJr. Prophylactic antibiotic practices for colectomy in Michigan. Am J Surg 2011;201(3):290–293.
210.Riley MM, Suda D, Tabsh K, Flood A, Pegues DA. Reduction of surgical site infections in low transverse cesarean section at a university hospital. Am J Infect Control 2012;40(9):820–825.
211.Lipke VL, Hyott AS. Reducing surgical site infections by bundling multiple risk reduction strategies and active surveillance. AORN J 2010;92(3):288–296.
212.Schwann NM, Bretz KA, Eid S, et al. Point-of-care electronic prompts: an effective means of increasing compliance, demonstrating quality, and improving outcome. Anesth Analg 2011; 113(4):869–876.
213.Berenguer CM, Ochsner MG Jr, Lord SA, Senkowski CK. Improving surgical site infections: using National Surgical Quality Improvement Program data to institute Surgical Care Improvement Project protocols in improving surgical outcomes. J Am Coll Surg 2010;210(5):737–741.
214.Restie JR, Riva-Cambrin J, Wellons JC 3rd, et al. A standardized protocol to reduce cerebrospinal fluid shunt infection: the Hydrocephalus Clinical Research Network Quality Improvement Initiative. J Neurosurg Pediatr 2011;8(1):22–29.
215.Horan TC, Gaynes RP, Mattone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13(10):606–608.
216.Kaye KS, Schmit K, Pieper C, et al. The effect of increasing age on the risk of surgical site infection. J Infect Dis 2005; 191(7):1056–1062.
217.Pessaux P, Msika S, Atalia D, Hay JM, Flamant Y.Risk factors for postoperative infectious complications in noncolorectal abdominal surgery: a multivariate analysis based on a prospective multicenter study of 4718 patients. Arch Surg 2003;138(3):314–324.
218.Raymond DP, Pelletier SJ, Crabtree TD, Schulman AM, Pruett TL, Sawyer RG. Surgical infection and the aging population. Am Surg 2001;67(9):827–832.
219.Olsen MA, Lefta M, Dietz JR, et al. Risk factors for surgical site infection after major breast operation. J Am Coll Surg 2008; 207(3):326–335.
220.Faraday N, Rock P, Lin EE, et al. Past history of skin infection and risk of surgical site infection after elective surgery. Ann Surg 2013;257(1):150–154.
221.Forse RA, Karam B, MacLean LD, Christou NV. Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery 1989;106(4):750–756.
222.Hawn MT, Houston TK, Campagna EJ, et al. The attributable risk of smoking on surgical complications. Ann Surg 2011; 254(6):914–920.
223.Moller AM, Pedersen T, Villebro N, Munksgaard A.Effect of smoking on early complications after elective orthopaedic surgery. J Bone Joint Surg Br 2003;85(2):178–181.
224.Moller AM, Villebro N, Pedersen T, Tonnesen H.Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 2002;359(9301):114—117.
225.Sharma A, Deeb AP, Iannuzzi JC, Rickles AS, Monson JR, Fleming FJ. Tobacco smoking and postoperative outcomes after colorectal surgery. Ann Surg 2013;258(2):296–300.
226.Theadom A, Cropley M.Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: a systematic review. Tob Control 2006;15(5):352–358.
227.Hennessey DB, Burke JP, Ni-Dhonochu T, Shields C, Winter DC, Mealy K.Preoperative hypoalbuminemia is an independent risk factor for the development of surgical site infection following gastrointestinal surgery: a multi-institutional study. Ann Surg 2010;252(2):325–329.
228.Boyce JM, Pittet D; Society for Healthcare Epidemiology of America, Association for Professionals in Infection Control, Infectious Diseases Society of America. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Recomm Rep 2002;51(RR-16)1–45.
229.Ford CD, Van Moorleghem G, Menlove RL. Blood transfusions and postoperative wound infection. Surgery 1993;113(6):603–607.
230.Horvath KA, Acker MA, Chang H, et al. Blood transfusion and infection after cardiac surgery. Ann Thorac Surg 2013;95(6):2194–2201.
231.Olsen MA, Lock-Buckley P, Hopkins D, Polish LB, Sundt TM, Fraser VJ. The risk factors for deep and superficial chest surgical-site infections after coronary artery bypass graft surgery are different. J Thorac Cardiovasc Surg 2002;124(1):136–145.
234.Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924–926.